Lodewijk J.R. de Vink Elected Director of NYNEX Corporation

July 20, 1995

NYNEX CONTACT: Media Relations,
(212) 395-0500

Lodewijk J.R. de Vink Elected Director of NYNEX Corporation

NEW YORK CITY -- The Board of Directors of NYNEX Corporation
today elected Lodewijk J.R. de Vink a director of the corporation.

Mr. de Vink, 50, is president and chief operating officer of
Warner-Lambert Company, one of the world's leading producers of consumer
health and personal care, pharmaceutical and confectionary products.

Headquartered in Morris Plains, New Jersey, Warner-Lambert markets
such well-known brands as Listerine, Rolaids, Certs, Clorets, Halls,
Benadryl, Sudafed, Efferdent, Neosporin, Caladryl, Schick, Wilkinson,
Dentyne and Trident to consumers in more than 140 countries worldwide.
The Company is also the world's largest producer of hard-gelatin capsules
and a major manufacturer and marketer of ethical and generic
pharmaceuticals. With $6.4 billion in net sales and a 43 percent return
on shareholders equity in 1994, Warner-Lambert is ranked 80th in market
value of the Fortune 500.

"Warner-Lambert knows how to market an extraordinary variety of
products to consumers in a wide range of countries and cultures," said
NYNEX Chairman and Chief Executive Officer Ivan G. Seidenberg.
"Lodewijk's experience and guidance will be critical to NYNEX as we set
out to satisfy new customers in a global multimedia industry."

Mr. de Vink attended the Netherlands School of Business and holds
a B.B.A. from Washburn University and an M.B.A. from American University.

He began his career at Schering-Plough Corporation, holding
positions of increasing responsibility for marketing in Canada, Europe,
the Middle East and Africa before being named president of Schering
International in 1986. He joined Warner- Lambert in 1988 as vice
president of international operations, becoming president of that division
and then president of U.S. operations. He was elected president and chief
operating officer of Warner-Lambert Company in August 1991.

Mr. de Vink is chairman of the Pharmaceutical Research and
Manufacturers of America and a member of the executive committee of the
Pharmaceutical Partners for Better Health Care. He is a trustee of the
National Foundation for Infectious Diseases and a member of Nijenrode
University's international advisory board. He is also a director of
Morristown Memorial Hospital in Morristown, N.J., the Friends of
Hassenfeld and the National Actors Theatre.

NYNEX is a global communications and media company that provides
a full range of services in the northeastern United States and
high-growth markets around the world, including the United Kingdom,
Thailand, Gibraltar, Greece, Indonesia, the Philippines, Poland,
Slovakia and the Czech Republic.

The Corporation is a leader in the telecommunications, wireless communications,
cable television, directory publishing
and entertainment and information services.

FAX copies of recent NYNEX news releases are available free of charge, 24
a day. Call 1-800-331-1214 and an automated system will provide